International Biotechnology (LON:IBT) Share Price Crosses Above 200 Day Moving Average – Time to Sell?

International Biotechnology (LON:IBT) passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 683.02 ($8.40) and traded as high as GBX 699.84 ($8.61). International Biotechnology shares last traded at GBX 692 ($8.51), with a volume of 53,428 shares changing hands.

International Biotechnology Price Performance

The company has a fifty day simple moving average of GBX 695.12 and a 200 day simple moving average of GBX 683.15. The stock has a market capitalization of £255.76 million, a price-to-earnings ratio of 1,441.67 and a beta of 0.21. The company has a debt-to-equity ratio of 9.66, a quick ratio of 0.32 and a current ratio of 0.46.

International Biotechnology Increases Dividend

The business also recently disclosed a dividend, which will be paid on Friday, January 24th. Investors of record on Thursday, December 19th will be paid a GBX 15.56 ($0.19) dividend. This is a positive change from International Biotechnology’s previous dividend of $14.50. This represents a dividend yield of 2.21%. The ex-dividend date is Thursday, December 19th. International Biotechnology’s payout ratio is currently 6,041.67%.

Insider Activity at International Biotechnology

In other International Biotechnology news, insider Katherine Cornish-Bowden acquired 1,500 shares of the company’s stock in a transaction dated Tuesday, December 17th. The shares were bought at an average cost of GBX 713 ($8.77) per share, with a total value of £10,695 ($13,159.84). 4.18% of the stock is currently owned by company insiders.

International Biotechnology Company Profile

International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments.